Edesa Biotech, Inc. Common Shares (EDSA) Dividend History

Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative treatments for inflammatory and immune-related diseases. The company specializes in leveraging its proprietary microscopic antibody technology to create therapies that address unmet medical needs. Edesa's research primarily targets conditions such as allergic and autoimmune diseases, aiming to advance novel therapeutic options in these areas.

100 Spy Court, Markham, A6, L3R 5H6
Phone: (905) 475-1234
Website:

Dividend History

Edesa Biotech, Inc. Common Shares currently does not pay dividends

Company News

  • Dr. Pardeep Nijhawan and Velan Capital have updated their beneficial ownership of securities in Edesa Biotech, Inc. Dr. Nijhawan acquired 100 Series B-1 Convertible Preferred Shares, while Velan Capital acquired 568 Series B-1 Convertible Preferred Shares, both for investment purposes.

    GlobeNewswire Inc.
  • Dr. Pardeep Nijhawan, the CEO of Edesa Biotech, Inc., has acquired beneficial ownership of more than 2% of the company's common shares through a series of transactions and the granting of restricted share units.

    GlobeNewswire Inc.
  • Shares of ReShape Lifesciences Inc. (NASDAQ: RSLS) rose sharply in pre-market trading after the company said it received FDA PMA supplement approval for its next-generation Lap-Band 2.0 FLEX. ReShape Lifesciences shares jumped 44.6% to $0.3630 in pre-market trading. Here are some other stocks moving in pre-market trading. Gainers RiskOn International, Inc. (NASDAQ: ROI) shares rose 84.3% to $0.2678 in pre-market trading after declining 9% on Tuesday. Innovative International Acquisition Corp. (NASDAQ: IOAC) shares rose 28.6% to $10.93 in pre-market trading. C4 Therapeutics, Inc. (NASDAQ: CCCC) gained 28.6% to $3.01 in pre-market trading after the company announced positive data from CFT7455 Phase 1 trial in relapsed/refractory multiple myeloma. Stifel upgraded C4 Therapeutics from Hold to Buy and raised the price target from $2 to $12. Mynaric AG (NASDAQ: MYNA) shares surged 16.9% to $5.60 in pre-market trading after the company received a $33 million order from Northrop Grumman. MyMD Pharmaceuticals, Inc. (NASDAQ:

    Benzinga
    Featured Companies: ATNF BURU CCCC CISO INAB RSLS SFWL VSME WLGS ZJYL
  • Shares of Urban Outfitters, Inc. (NASDAQ: URBN) dipped during Wednesday’s session after the company reported third-quarter financial results. Urban Outfitters reported quarterly earnings of 88 cents per share, topping the analyst consensus estimate of 82 cents per share. The company reported record quarterly sales of $1.28 billion which exceeded analyst expectations of $1.26 billion, according to data from Benzinga Pro. Urban Outfitters shares fell 9.9% to $32.73 on Wednesday. Here are some other stocks moving in today's mid-day session. Gainers AgileThought, Inc. (NASDAQ: AGIL) shares jumped 206.4% to $0.2514 after gaining 5% on Tuesday. PaxMedica, Inc. (NASDAQ: PXMD) rose 33% to $1.08 as the company announced pricing of $7 million public offering. SciSparc Ltd. (NASDAQ: SPRC) gained 29.5% to $8.25 after the company announced it signed a non-binding letter of intent to merge with a vehicle importer company in Israel. Agape ATP Corporation (NASDAQ: ATPC) climbed 22% to $1.15. Agape ATP announced a $1 million share repurchase plan over the next 6 months. Ryvyl Inc. (NASDAQ: RVYL) rose 21.6% to $3.77. The company recently posted a narrower loss for the third quarter. Heart Test Laboratories, Inc. (NASDAQ: HSCS) shares rose 19.3% to $0.2340. HeartSciences recently announced closing ...

    Benzinga
  • Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc. Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares climbed 102% to $0.7961 after gaining more than 6% on Thursday. Shift Technologies, Inc. (NASDAQ: SFT) gained 60% to $0.2145, after falling around 21% on Thursday. C3is Inc. (NASDAQ: CISS) gained 32% to $0.5625. Comtech Telecommunications Corp. (NASDAQ: CMTL) shares climbed 30.6% to $10.63 after posting better-than-expected fourth-quarter results. Versus Systems Inc. (NASDAQ: VS) shares climbed 29.1% to $0.4246 after jumping more than 52% on Thursday. Outlook Therapeutics, Inc. (NASDAQ: OTLK) gained 26% to $0.3448 SunOpta Inc. (NASDAQ: STKL) gained 22.5% to $3.5050 after the company announced the sale of certain frozen fruit assets to Nature's Touch for an aggregate purchase price of $141 million and issued preliminary Q3 results. PSQ Holdings, Inc. (NYSE: PSQH) climbed 22% to $5.55. The company said preliminary third quarter revenue climbed around 300% sequentially, to an estimated $2.2 million, representing 1,600% year-over-year growth. EHang Holdings Limited (NASDAQ: EH) jumped 21% to $20.77 after the company obtained a type certificate for the EH216-S passenger-carrying UAV system issued by the Civil Aviation Administration of China. SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) gained 18% to $1.27. SELLAS Life Sciences issued an update on Phase 3 REGAL clinical trial for Galinpepimut-S in acute myeloid leukemia. Celularity Inc. (NASDAQ: CELU) rose 17.7% to $0.3179. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) gained 16% to $0.3826. Hecla Mining Company (NYSE: HL) climbed 13.7% to $4.1650 after Roth MKM upgraded the stock from Neutral to Buy and raised its price target from $4 to $4.4. Viasat, Inc. (NASDAQ: VSAT) climbed 13.5% to $19.06. Coeur Mining, Inc. (NYSE: CDE) gained 13.2% to $2.5399. Groupon, Inc. (NASDAQ: GRPN) jumped 13.2% to $12.38 after Roth MKM initiated coverage on the stock with a Buy rating and $30 price target. Synchronoss Technologies, Inc. (NASDAQ: SNCR) surged 13% to $0.5426. Oblong, Inc. (NASDAQ:

    Benzinga
Dividend data last updated 06/07/2025 18:24:25 UTC